KCR Partners with Veeva for Fully Digitalized Trial Execution Solutions
Boston, MA, 18 March 2021 — KCR, the international clinical development solutions provider, continues further in the development and implementation of Veeva Clinical Data Management Systems and Veeva Quality Management Solutions. As the first CRO in Europe implementing Veeva Vault Clinical Documentation solutions, KCR has been expanding its digital research platform with Veeva products since 2014. This year KCR is extending its offer with the Veeva Clinical Data Management Suite, which combines electronic data capture (EDC), coding, data cleaning, and reporting.
Continuously improving clinical trial performance is one of KCR’s top priorities, therefore we are determined to use state-of-art technology and high-quality data handling services for all types and sizes of clinical research projects. The Veeva Vault Suite brings the same level of quality, data transparency, and process efficiency for medium or large pharma, as well as biotechnology companies.
With this scalable business approach, the difference between a company’s size and project budget becomes insignificant for technology choices. That is a crucial change in the clinical research industry from which Sponsors, CROs, sites and patients will benefit more and more having real-time access to global data that safeguards health and lives.
If you would like to learn more about KCR technology for Trial Execution Solutions, please contact us at pr@kcrcro.com.
About KCR:
KCR is a clinical development solutions provider for the biotechnology and pharmaceutical industries. We support clients with full-service clinical development capabilities across three main areas: Trial Execution, Consulting and Placement. KCR operates now across five regions: North America, Western Europe, Central Europe, Eastern Europe, and Australia, with a main operational hub located in Boston, MA. Our strategic hub locations, technical capabilities and solution offerings allow for the optimized delivery of trial execution strategies to develop life-changing therapies. KCR offers access to an estimated population of 1.1 Billion people.
For more information visit www.kcrcro.com.
We see the human behind every number.
###
Contact:
Molly Garrity
KCR, PR & Marketing
E-mail: molly.garrity@kcrcro.com
Mobile: +1 857 753 7853
